Several mitochondria-related genes were differentially expressed between parental and resistant GBM cells, and among them, the superoxide dismutase 2 (SOD2) gene substantially affected various factors, including cancer stemness, treatment resistance, and patient survival [7]. This evidence concerns the gene SOD2 and cancer.